{"Ticker": "CTLT", "Company": "Catalent", "Sector": "Health Care", "Updated": "2023-04-17", "Rating": [{"Date": "2023-04-17", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$82 to $53"}, {"Date": "2023-04-14", "Rating": "Downgrade", "Organization": "William Blair", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}, {"Date": "2023-04-10", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$79 to $88"}, {"Date": "2023-04-03", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$70"}, {"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight to Sector Weight", "Target_Change": ""}, {"Date": "2022-11-07", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-11-02", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$125 to $60"}, {"Date": "2021-12-16", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$160"}, {"Date": "2020-12-10", "Rating": "Upgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Sector Weight to Overweight", "Target_Change": "$120"}, {"Date": "2020-06-25", "Rating": "Initiated", "Organization": "Argus", "Rating_Change": "Buy", "Target_Change": "$100"}, {"Date": "2020-04-21", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$65"}, {"Date": "2020-03-02", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": ""}, {"Date": "2019-10-17", "Rating": "Resumed", "Organization": "Stephens", "Rating_Change": "Overweight", "Target_Change": "$56"}, {"Date": "2019-08-28", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight to Sector Weight", "Target_Change": ""}, {"Date": "2019-06-21", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$50 to $62"}, {"Date": "2019-04-16", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$43 to $54"}, {"Date": "2018-11-07", "Rating": "Upgrade", "Organization": "First Analysis Sec", "Rating_Change": "Neutral to Outperform", "Target_Change": "$47 to $43"}, {"Date": "2018-10-09", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": ""}, {"Date": "2018-03-28", "Rating": "Upgrade", "Organization": "KeyBanc Capital Mkts", "Rating_Change": "Sector Weight to Overweight", "Target_Change": ""}, {"Date": "2018-03-21", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": ""}, {"Date": "2018-02-06", "Rating": "Downgrade", "Organization": "Stephens", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": ""}, {"Date": "2017-09-21", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": ""}, {"Date": "2017-09-13", "Rating": "Initiated", "Organization": "Needham", "Rating_Change": "Hold", "Target_Change": ""}, {"Date": "2017-09-08", "Rating": "Downgrade", "Organization": "KeyBanc Capital Mkts", "Rating_Change": "Overweight to Sector Weight", "Target_Change": ""}, {"Date": "2016-12-01", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": ""}, {"Date": "2016-10-20", "Rating": "Initiated", "Organization": "KeyBanc Capital Mkts", "Rating_Change": "Overweight", "Target_Change": "$29"}, {"Date": "2016-06-21", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Market Perform to Outperform", "Target_Change": ""}]}